Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.38
+0.4%
$2.68
$1.72
$73.50
$2.38M0.38359,332 shs28,512 shs
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
$1.34
-8.2%
$1.31
$0.95
$6.22
$5.39M0.662.18 million shs103,344 shs
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$0.01
-4.7%
$0.02
$0.01
$0.09
N/AN/A22,431 shs4,053 shs
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$0.10
-1.7%
$0.17
$0.08
$2.96
$1.56M-0.1414.22 million shs984,724 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-2.86%+1.28%-51.13%-96.56%
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
0.00%-5.63%+13.56%+3.08%-75.02%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
0.00%-20.79%-35.91%-10.76%-33.49%
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
0.00%+2.28%-39.37%-61.64%-95.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.38
+0.4%
$2.68
$1.72
$73.50
$2.38M0.38359,332 shs28,512 shs
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
$1.34
-8.2%
$1.31
$0.95
$6.22
$5.39M0.662.18 million shs103,344 shs
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$0.01
-4.7%
$0.02
$0.01
$0.09
N/AN/A22,431 shs4,053 shs
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$0.10
-1.7%
$0.17
$0.08
$2.96
$1.56M-0.1414.22 million shs984,724 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00%-2.86%+1.28%-51.13%-96.56%
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
0.00%-5.63%+13.56%+3.08%-75.02%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
0.00%-20.79%-35.91%-10.76%-33.49%
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
0.00%+2.28%-39.37%-61.64%-95.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
1.00
SellN/AN/A
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
1.00
SellN/AN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
0.00
N/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
2.25
Hold$6.255,956.20% Upside

Current Analyst Ratings Breakdown

Latest ATPC, DRMA, SNYR, and DSYWW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
DowngradeSell (D-)Sell (E+)
8/19/2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
Reiterated RatingSell (E+)
8/10/2026
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
UpgradeStrong SellHold
7/28/2026
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
UpgradeSell (E)Sell (E+)
7/10/2026
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
DowngradeSell (E+)Sell (E)
6/29/2026
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
UpgradeSell (E+)Sell (D-)
6/23/2026
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
UpgradeSell (E)Sell (E+)
6/12/2026
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
DowngradeHoldStrong Sell
6/11/2026
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
DowngradeSell (D-)Sell (E+)
6/4/2026
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
DowngradeSell (E+)Sell (E)
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.52M1.57N/AN/A$22.04 per share0.11
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
N/AN/AN/AN/A$0.87 per shareN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
$2.02MN/AN/AN/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$30.38M0.05N/AN/A($2.06) per share-0.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.28M-$0.74N/AN/AN/A-85.94%-5.47%-4.94%N/A
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
-$7.56M-$4.39N/AN/AN/AN/A-166.66%-130.13%11/18/2026 (Estimated)
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
-$12.34M-$1.40N/A0.69N/A-60.02%N/A-30.30%N/A

Latest ATPC, DRMA, SNYR, and DSYWW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A$0.15N/A$0.15N/A$0.01 million
8/11/2026Q2 2026
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
-$0.55-$0.74-$0.19-$0.74N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
N/AN/AN/AN/AN/A
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/AN/AN/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
8.45
8.44
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
N/A
2.81
2.73
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/A
0.93
0.43

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
8.67%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/A

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
2.04%
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
21.90%
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
N/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
32.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
401.00 million981,000Not Optionable
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
84.02 million3.14 millionNot Optionable
Big Tree Cloud Holdings Limited stock logo
DSYWW
Big Tree Cloud
82N/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
4015.08 million10.12 millionN/A

Recent News About These Companies

Synergy CHC Corp. Announces Receipt of Nasdaq Letter
Synergy CHC Corp. Stock Short Interest Rises to 42.12%
Synergy CHC (SNYR)
Synergy CHC Corp SNYR
Synergy Hesitates on Quarterly Numbers

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.38 +0.01 (+0.42%)
As of 08/28/2026 04:00 PM Eastern

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Dermata Therapeutics stock logo

Dermata Therapeutics NASDAQ:DRMA

$1.34 -0.12 (-8.22%)
As of 08/28/2026 04:00 PM Eastern

Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Big Tree Cloud stock logo

Big Tree Cloud NASDAQ:DSYWW

$0.01 0.00 (-4.73%)
As of 08/28/2026 03:43 PM Eastern

Big Tree Cloud Holdings Limited manufactures and sells personal care products and other consumer goods. The company is based in Shenzhen, China. Big Tree Cloud Holdings Limited operates as a subsidiary of Ploutos Group Limited.

Synergy CHC stock logo

Synergy CHC NASDAQ:SNYR

$0.10 0.00 (-1.71%)
As of 08/28/2026 04:00 PM Eastern

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.